* We recommend a score >= 0.08 for meaningful Gene-Disease associations

GeneID	Gene_Symbol	DisGeNet_diseaseID	Disease_name	DisGeNet score	DisGeNet_sourceDB
5335	PLCG1	C0005586	Bipolar Disorder	0.205088783830789	BEFREE;GAD;PSYGENET
5335	PLCG1	C0018923	Hemangiosarcoma	0.201098907136852	BEFREE;CTD_human
5335	PLCG1	C0079773	Lymphoma, T-Cell, Cutaneous	0.200549453568426	BEFREE;CTD_human
5335	PLCG1	C0036920	Sezary Syndrome	0.2	CTD_human
5335	PLCG1	C0023493	Adult T-Cell Lymphoma/Leukemia	0.2	CTD_human
5335	PLCG1	C0009404	Colorectal Neoplasms	0.00273291246481375	LHGDN
5335	PLCG1	C0023418	leukemia	0.00273291246481375	LHGDN
5335	PLCG1	C0026769	Multiple Sclerosis	0.002407028523288	GAD
5335	PLCG1	C0019693	HIV Infections	0.002407028523288	GAD
5335	PLCG1	C3463824	MYELODYSPLASTIC SYNDROME	0.0013736339210655	BEFREE
5335	PLCG1	C0027627	Neoplasm Metastasis	0.0013736339210655	BEFREE
5335	PLCG1	C0006142	Malignant neoplasm of breast	0.0010989071368524	BEFREE
5335	PLCG1	C0678222	Breast Carcinoma	0.0010989071368524	BEFREE
5335	PLCG1	C0600139	Prostate carcinoma	0.0008241803526393	BEFREE
5335	PLCG1	C0009402	Colorectal Carcinoma	0.0005494535684262	BEFREE
5335	PLCG1	C0376358	Malignant neoplasm of prostate	0.0005494535684262	BEFREE
5335	PLCG1	C0278701	Gastric Adenocarcinoma	0.0005494535684262	BEFREE
5335	PLCG1	C0153676	Secondary malignant neoplasm of lung	0.0005494535684262	BEFREE
5335	PLCG1	C0023467	Leukemia, Myelocytic, Acute	0.0005494535684262	BEFREE
5335	PLCG1	C1527249	Colorectal Cancer	0.0002747267842131	BEFREE
5335	PLCG1	C0862196	mycosis fungoides/Sezary syndrome	0.0002747267842131	BEFREE
5335	PLCG1	C0699791	Stomach Carcinoma	0.0002747267842131	BEFREE
5335	PLCG1	C0699790	Colon Carcinoma	0.0002747267842131	BEFREE
5335	PLCG1	C0007137	Squamous cell carcinoma	0.0002747267842131	BEFREE
5335	PLCG1	C0007102	Malignant tumor of colon	0.0002747267842131	BEFREE
5335	PLCG1	C0677886	Epithelial ovarian cancer	0.0002747267842131	BEFREE
5335	PLCG1	C1710547	Unilateral Breast Carcinoma	0.0002747267842131	BEFREE
5335	PLCG1	C2239176	Liver carcinoma	0.0002747267842131	BEFREE
5335	PLCG1	C0017668	Focal glomerulosclerosis	0.0002747267842131	BEFREE
5335	PLCG1	C0596263	Carcinogenesis	0.0002747267842131	BEFREE
5335	PLCG1	C0549463	X-Linked Lymphoproliferative Disorder	0.0002747267842131	BEFREE
5335	PLCG1	C0524620	Metabolic Syndrome X	0.0002747267842131	BEFREE
5335	PLCG1	C0400966	Non-alcoholic Fatty Liver Disease	0.0002747267842131	BEFREE
5335	PLCG1	C0349631	Richter's syndrome	0.0002747267842131	BEFREE
5335	PLCG1	C0349530	Early gastric cancer	0.0002747267842131	BEFREE
5335	PLCG1	C0345907	Angiosarcoma of liver	0.0002747267842131	BEFREE
5335	PLCG1	C0342418	Hypothalamic hamartomas	0.0002747267842131	BEFREE
5335	PLCG1	C0342276	Maturity onset diabetes mellitus in young	0.0002747267842131	BEFREE
5335	PLCG1	C0178874	Tumor Progression	0.0002747267842131	BEFREE
5335	PLCG1	C0149521	Pancreatitis, Chronic	0.0002747267842131	BEFREE
5335	PLCG1	C0042109	Urticaria	0.0002747267842131	BEFREE
5335	PLCG1	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.0002747267842131	BEFREE
5335	PLCG1	C0029408	Degenerative polyarthritis	0.0002747267842131	BEFREE
5335	PLCG1	C0014544	Epilepsy	0.0002747267842131	BEFREE
5335	PLCG1	C0017636	Glioblastoma	0.0002747267842131	BEFREE
5335	PLCG1	C0024623	Malignant neoplasm of stomach	0.0002747267842131	BEFREE
5335	PLCG1	C0024121	Lung Neoplasms	0.0002747267842131	BEFREE
5335	PLCG1	C0017638	Glioma	0.0002747267842131	BEFREE